Selvaraj D - Search Results

1

Gene network analysis combined with preclinical studies to identify and elucidate the mechanism of action of novel irreversible Keap1 inhibitor for Parkinson's disease.

Arumugam M, Pachamuthu RS, Rymbai E, Jha AP, Rajagopal K, Kothandan R, Muthu S, Selvaraj D. Arumugam M, et al. Among authors: selvaraj d. Mol Divers. 2024 Aug 15. doi: 10.1007/s11030-024-10965-y. Online ahead of print. Mol Divers. 2024. PMID: 39145879

2

Quillaja saponin: A prospective emulsifier for the preparation of solid lipid nanoparticles.

Karthik S, Raghavan CV, Marslin G, Rahman H, Selvaraj D, Balakumar K, Franklin G. Karthik S, et al. Among authors: selvaraj d. Colloids Surf B Biointerfaces. 2016 Nov 1;147:274-280. doi: 10.1016/j.colsurfb.2016.07.065. Epub 2016 Aug 1. Colloids Surf B Biointerfaces. 2016. PMID: 27521748

3

Syringaresinol as a novel androgen receptor antagonist against wild and mutant androgen receptors for the treatment of castration-resistant prostate cancer: molecular docking, in-vitro and molecular dynamics study.

Selvaraj D, Muthu S, Kotha S, Siddamsetty RS, Andavar S, Jayaraman S. Selvaraj D, et al. J Biomol Struct Dyn. 2021 Feb;39(2):621-634. doi: 10.1080/07391102.2020.1715261. Epub 2020 Jan 25. J Biomol Struct Dyn. 2021. PMID: 31928160

4

Importance of Fibrosis in the Pathogenesis of Uterine Leiomyoma and the Promising Anti-fibrotic Effects of Dipeptidyl Peptidase-4 and Fibroblast Activation Protein Inhibitors in the Treatment of Uterine Leiomyoma.

Bhat AS, Singh NA, Rymbai E, Birendra S, Jayaram S, Selvaraj D. Bhat AS, et al. Among authors: selvaraj d. Reprod Sci. 2023 May;30(5):1383-1398. doi: 10.1007/s43032-022-01064-0. Epub 2022 Aug 15. Reprod Sci. 2023. PMID: 35969363 Review.

5

A preliminary study to identify existing drugs for potential repurposing in breast cancer based on side effect profile.

Rymbai E, Sugumar D, Krishnamurthy PT, Selvaraj D, Vasu S, Priya S, Jayaram S. Rymbai E, et al. Among authors: selvaraj d. Drug Res (Stuttg). 2023 Jun;73(5):296-303. doi: 10.1055/a-2011-5662. Epub 2023 Mar 6. Drug Res (Stuttg). 2023. PMID: 36878466

6

Side effects based network construction and drug repositioning of ropinirole as a potential molecule for Alzheimer's disease: an in-silico, in-vitro, and in-vivo study.

Chakkittukandiyil A, Chakraborty S, Kothandan R, Rymbai E, Muthu SK, Vasu S, Sajini DV, Sugumar D, Mohammad ZB, Jayaram S, Rajagopal K, Ramachandran V, Selvaraj D. Chakkittukandiyil A, et al. Among authors: selvaraj d. J Biomol Struct Dyn. 2024;42(20):10785-10799. doi: 10.1080/07391102.2023.2258968. Epub 2023 Sep 18. J Biomol Struct Dyn. 2024. PMID: 37723871

7

The identification of cianidanol as a selective estrogen receptor beta agonist and evaluation of its neuroprotective effects on Parkinson's disease models.

Rymbai E, Sugumar D, Chakkittukandiyil A, Kothandan R, Selvaraj J, Selvaraj D. Rymbai E, et al. Among authors: selvaraj j, selvaraj d. Life Sci. 2023 Nov 15;333:122144. doi: 10.1016/j.lfs.2023.122144. Epub 2023 Oct 4. Life Sci. 2023. PMID: 37797687

8

Network-based drug repositioning of linagliptin as a potential agent for uterine fibroids targeting transforming growth factor-beta mediated fibrosis.

Bhat AS, Chakkittukandiyil A, Muthu SK, Kotha S, Muruganandham S, Rajagopal K, Jayaram S, Kothandan R, Selvaraj D. Bhat AS, et al. Among authors: selvaraj d. Biochem Biophys Res Commun. 2024 Apr 9;703:149611. doi: 10.1016/j.bbrc.2024.149611. Epub 2024 Feb 8. Biochem Biophys Res Commun. 2024. PMID: 38354463

9

Molecular insights into the potential effects of selective estrogen receptor β agonists in Alzheimer's and Parkinson's diseases.

Rymbai E, Sugumar D, Chakkittukandiyil A, Kothandan R, Selvaraj D. Rymbai E, et al. Among authors: selvaraj d. Cell Biochem Funct. 2024 Apr;42(3):e4014. doi: 10.1002/cbf.4014. Cell Biochem Funct. 2024. PMID: 38616346 Review.

10

Ligandrol Ameliorates High-Fat Diet- and Streptozotocin-Induced Type 2 Diabetes Mellitus and Prevents Pancreatic Islets Degeneration.

Sugumar D, Ghosh R, Rymbai E, Chandrasekaran J, Krishnamurthy PT, P RS, Sahu S, Selvaraj D. Sugumar D, et al. Among authors: selvaraj d. Assay Drug Dev Technol. 2024 Nov 6. doi: 10.1089/adt.2024.029. Online ahead of print. Assay Drug Dev Technol. 2024. PMID: 39501873

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters